1. An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating. (14th July 2022) Authors: Eryilmaz, Isil Ezgi; Egeli, Unal; Cecener, Gulsah Journal: Clinical and experimental pharmacology and physiology Issue: Volume 49:Number 10(2022) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells. (July 2021) Authors: Guney Eskiler, Gamze; Ozkan, Asuman Deveci; Eryilmaz, Isil Ezgi; Egeli, Unal; Cecener, Gulsah Journal: Human & experimental toxicology Issue: Volume 40:Number 7(2021) Page Start: 1122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. Issue 5 (23rd January 2019) Authors: Guney Eskiler, Gamze; Cecener, Gulsah; Egeli, Unal; Tunca, Berrin Journal: Journal of biochemical and molecular toxicology Issue: Volume 33:Issue 5(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients. (14th September 2014) Authors: Cecener, Gulsah; Egeli, Unal; Tunca, Berrin; Erturk, Elif; Ak, Secil; Gokgoz, Sehsuvar; Tasdelen, Ismet; Tezcan, Gulcin; Demirdogen, Elif; Bayram, Nuran; Avci, Nilufer; Evrensel, Turkkan Journal: Cancer investigation Issue: Volume 32:Number 8(2014) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Coexistence of MACC1 and NM23‐H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early‐stage colon cancer. Issue 2 (25th January 2018) Authors: Ozturk, Ersin; Aksoy, Secil AK; Ugras, Nesrin; Tunca, Berrin; Ceylan, Serkan; Tezcan, Gulcin; Yilmazlar, Tuncay; Yerci, Omer; Egeli, Unal; Cecener, Gulsah Journal: Apmis Issue: Volume 126:Issue 2(2018) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions. (2nd November 2017) Authors: Eryilmaz, Isil Ezgi; Cecener, Gulsah; Erer, Sevda; Egeli, Unal; Tunca, Berrin; Zarifoglu, Mehmet; Elibol, Bulent; Bora Tokcaer, Ayse; Saka, Esen; Demirkiran, Meltem; Akbostanci, Cenk; Dogu, Okan; Colakoglu, Beril; Kenangil, Gulay; Kaleagasi, Hakan Journal: Neurological research Issue: Volume 39:Number 11(2017) Page Start: 965 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evaluation of the Clinical Features Accompanied by the Gene Mutations: The 2 Novel PSEN1 Variants in a Turkish Early-onset Alzheimer Disease Cohort. (July 2021) Authors: Eryilmaz, Isil E.; Bakar, Mustafa; Egeli, Unal; Cecener, Gulsah; Yurdacan, Beste; Colak, Dilara K.; Tunca, Berrin Journal: Alzheimer disease and associated disorders Issue: Volume 35:Number 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. In vitro cytotoxic and antiproliferative effects of usnic acid on hormone‐dependent breast and prostate cancer cells. Issue 10 (13th August 2018) Authors: Eryilmaz, Isil Ezgi; Guney Eskiler, Gamze; Egeli, Unal; Yurdacan, Beste; Cecener, Gulsah; Tunca, Berrin Journal: Journal of biochemical and molecular toxicology Issue: Volume 32:Issue 10(2018) Page Start: N/A Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Inhibitory Effects of Olea europaea Leaf Extract on Mesenchymal Transition Mechanism in Glioblastoma Cells. (21st April 2021) Authors: Mutlu, Melis; Tunca, Berrin; Ak Aksoy, Secil; Tekin, Cagla; Egeli, Unal; Cecener, Gulsah Journal: Nutrition and cancer Issue: Volume 73:Number 4(2021) Page Start: 713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid. (25th April 2019) Authors: Yurdacan, Beste; Egeli, Unal; Guney Eskiler, Gamze; Eryilmaz, Isil Ezgi; Cecener, Gulsah; Tunca, Berrin Journal: Journal of pharmacy and pharmacology Issue: Volume 71:Number 7(2019) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗